fbpx

Resources

Nov 18, 2024

Understanding blue light: Making sense of the spectrum

By Thomas A. Wong, OD, FAAO, FNAP & Karl Citek, OD, PhD, FAAO A new classification system helps patients reach informed decisions.

Understanding blue light: Making sense of the spectrum

Nov 18, 2024

4 favorite foods with the most toxic plasticizers

By Anastasia Climan, RDN, CD-N | Fact-checked by Barbara Bekiesz | Published November 15, 2024 Key Takeaways The use of phthalates in food processing and packaging has led to widespread daily exposure, often in foods that are marketed…

4 favorite foods with the most toxic plasticizers

Nov 12, 2024

Pistachios take over carrots as ultimate weapon for better, sharper vision?

Scientists have found nutty substitute for people seeking to improve eye health but dislike carrot by: Web Desk November 11, 2024 Carrots are often hailed as a superfood for eye…

Pistachios take over carrots as ultimate weapon for better, sharper vision?

Nov 8, 2024

FDA grants de novo authorization to photobiomodulation device for dry AMD

Key takeaways: The light delivery system maintained vision in a trial among patients with dry age-related macular degeneration. It is the first authorized treatment for vision loss related to dry…

FDA grants de novo authorization to photobiomodulation device for dry AMD

Nov 7, 2024

Dropless cataract surgery: Shifting paradigm in postoperative care

Author(s): Monique M. Barbour, MD, Bria George, PharmD Key Takeaways Dropless cataract surgery eliminates postoperative eye drops, enhancing patient adherence and reducing complications like infection and inflammation. Intracameral drug delivery…

Dropless cataract surgery: Shifting paradigm in postoperative care

Nov 7, 2024

FDA clears investigational new drug application for wet AMD gene therapy

The FDA granted investigational drug clearance to HG202, a CRISPR/Cas13Y RNA-editing therapy for neovascular age-related macular degeneration, according to a press release from HuidaGene. According to the release, HG202 is the…

FDA clears investigational new drug application for wet AMD gene therapy

Nov 6, 2024

Intense pulsed light for treatment of dry eye disease

Author(s): David Hutton Joanne F. Shen, MD, director of the dry eye clinic at Mayo Clinic’s campus in Phoenix, Arizona, and a research team studied 35 patients treated with IPL/MGX.…

Intense pulsed light for treatment of dry eye disease

Nov 4, 2024

UV protection for the eyes: What patients need to know

October 29, 2024, By Cristina M. Schnider, OD, MSc, MBA, FAAO Many people know that invisible UV light can cause a sunburn and contribute to skin aging and skin cancer, but…

UV protection for the eyes: What patients need to know

Oct 29, 2024

Daily consumption of pistachios boosts macular pigment optical density in healthy adults

October 28, 2024 Key takeaways: Eating 2 oz. of pistachios daily for 12 weeks significantly increased macular pigment optical density. Serum lutein concentration also improved in the group that consumed…

Daily consumption of pistachios boosts macular pigment optical density in healthy adults

Oct 28, 2024

Genetic Links Explored: How inherited retinal dystrophies affect refractive errors in patients

Specific genes associated with inherited retinal dystrophies (IRDs) also influence refractive errors (RE), such as myopia and hyperopia, according to a study that found these genetic patterns vary widely, suggesting…

Genetic Links Explored: How inherited retinal dystrophies affect refractive errors in patients

Oct 28, 2024

Alkeus Pharmaceuticals announces topline results from SAGA trial on GA treatment

October 25, 2024 ew study about Geographic Atrophy  By Jordana Joy, Associate Editor The data showed a 15.3% reduction in the GA lesion growth rate versus placebo from 6 to 24…

Alkeus Pharmaceuticals announces topline results from SAGA trial on GA treatment

Oct 23, 2024

#GIVING TUESDAY 2024

SAVE THE DATE: Tuesday December 3rd, 2024 #GivingTuesday—a movement to create a global day of giving Today. We need your help to help those Living with Macular Degeneration On Tuesday,…

#GIVING TUESDAY 2024

Oct 22, 2024

Light therapy: Potential treatment for dry AMD

by: Lynda Charters Listen Key Takeaways Photobiomodulation may reduce visual loss and disease progression in dry AMD, offering a new treatment option for patients. The study showed significant visual acuity…

Light therapy: Potential treatment for dry AMD

Oct 7, 2024

Metformin Shows Promise for Treating Macular Degeneration in Mice

A new study shows metformin may help prevent vision loss associated with age-related macular degeneration. News Published: October 7, 2024 Original story from the University of Chicago Age-related macular degeneration…

Metformin Shows Promise for Treating Macular Degeneration in Mice

Sep 23, 2024

Alkeus Pharmaceuticals announces results from the SAGA study of oral gildeuretinol in patients with GA

September 19, 2024 By David Hutton Oral gildeuretinol demonstrated a clinically meaningful reduction in the geographic atrophy lesion growth rate at 24 months, supporting additional clinical development. SAGA topline data has…

Alkeus Pharmaceuticals announces results from the SAGA study of oral gildeuretinol in patients with GA

Sep 19, 2024

Eye Drop Company in FDA’s Sights Once Again

The agency sounds alarm that products still may contain amniotic fluid by Kristina Fiore, Director of Enterprise & Investigative Reporting, MedPage Today September 17, 2024 The FDA has sent another letter — this…

Eye Drop Company in FDA’s Sights Once Again

Sep 16, 2024

These foods sabotage sleep

By Julia Ries | Fact-checked by Davi Sherman | Published September 13, 2024 Key Takeaways Certain foods like chocolate, greasy snacks, and spicy dishes can disrupt sleep due to their effects on digestion and caffeine content.…

These foods sabotage sleep

Sep 12, 2024

The Changing Landscape of Nutrition in Medicine

A look at developments that have propelled us forward and those still to come for eye care. by: Julie Poteet, OD, MS, CNS, FOWNS At A Glance The increasing prevalence…

The Changing Landscape of Nutrition in Medicine

Sep 11, 2024

Up to 1 in 5 Dementia Cases May Be Attributable to Vision Impairment

Contrast sensitivity impairment showed the strongest relationship by Judy George, Deputy Managing Editor, MedPage TodaySeptember 5, 2024 Last Updated September 6, 2024 Key Takeaways Up to 19% of prevalent dementia cases may be…

Up to 1 in 5 Dementia Cases May Be Attributable to Vision Impairment

Sep 9, 2024

AiViva Biopharma completes enrollment in Phase 1 clinical trial of AIV007 for AMD, DME

By David Hutton The Phase 1 trial is a multicenter, open-label, dose-escalation safety clinical trial, with 18 subjects, who each have received a single periocular injection of AIV007 AiViva Biopharma Inc…

AiViva Biopharma completes enrollment in Phase 1 clinical trial of AIV007 for AMD, DME

Aug 21, 2024

AOA urges eye care provider consultation before use, purchase of MSM eye drops

August 20, 2024, By Jordana Joy, Associate Editor The alert follows a warning letter issued by the US FDA to a company that manufactures eye drops that claim to change eye…

AOA urges eye care provider consultation before use, purchase of MSM eye drops

Aug 15, 2024

Prevalence of AMD-related vision loss expected to increase as population ages

By Kate YoungFact checked by Heather Biele Key takeaways: Prevalence of AMD-related blindness decreased globally from 2000 to 2020. Older age is associated with greater prevalence of AMD-related vision loss.…

Prevalence of AMD-related vision loss expected to increase as population ages

Aug 12, 2024

Sandoz announces FDA approval for new biosimilar

New Press Release The U.S. Food and Drug Administration (FDA) has approved Sandoz biosimilar Enzeevu™ (aflibercept-abzv) 2 mg vial kit and pre-filled syringe for intravitreal injection. Enzeevu is indicated to…

Sandoz announces FDA approval for new biosimilar

Aug 12, 2024

Multivitamins could potentially shorten your lifespan

By Lisa Marie Basile | Fact-checked by Davi Sherman | Published July 16, 2024 Key Takeaways A new cohort study published in JAMA Network Open analyzed data from nearly 400,000 participants over 20 years and found that the use…

Multivitamins could potentially shorten your lifespan

Aug 9, 2024

Ocular Therapeutix receives FDA nod for SOL-R registrational study of Axpaxli

New Study Ocular Therapeutix obtained FDA support to use the phase 3 SOL-R trial as the next step in the regulatory process for Axpaxli, according to a press release. The FDA…

Ocular Therapeutix receives FDA nod for SOL-R registrational study of Axpaxli

Aug 6, 2024

AREDS2 supplement slows expansion of geographic atrophy, even in late-stage AMD

by: Steven Ferrucci, OD, FAAO Key takeaways: The AREDS2 supplement slowed the expansion of geographic atrophy toward the fovea by approximately 55% over 3 years in patients with dry AMD.…

AREDS2 supplement slows expansion of geographic atrophy, even in late-stage AMD

Jul 28, 2024

Stave off cognitive decline: Eat this mushroom

By Julia Ries | Fact-checked by Davi Sherman | Published July 25, 2024 Key Takeaways The lion’s mane mushroom is gaining popularity for its potential health benefits, particularly in supporting memory and preventing cognitive decline. Mushrooms, including…

Stave off cognitive decline: Eat this mushroom

Jul 26, 2024

Heart Pounding, Stomach-Knotting: Stress & You

The Stress Response Your muscles tense, your heart races and your breath comes faster — we all know what stress feels like. The “fight or flight” response is behind it:…

Heart Pounding, Stomach-Knotting: Stress & You

Jul 25, 2024

Could Metformin Fill the Bill for Geographic Atrophy Prevention?

Case-control study shows reduction in new-onset GA, particularly in nondiabetic patients by Charles Bankhead, Senior Editor, MedPage TodayJuly 22, 2024 STOCKHOLM — The risk of developing geographic atrophy (GA) declined significantly in…

Could Metformin Fill the Bill for Geographic Atrophy Prevention?

Jul 8, 2024

FDA approves Vabysmo prefilled syringe for retinal diseases

Key takeaways: The prefilled syringe is indicated for wet age-related macular degeneration, diabetic macular edema, and retinal vein occlusion. The syringe will be available in the U.S. later this year.…

FDA approves Vabysmo prefilled syringe for retinal diseases

Newsletter Sign-up

  • This field is for validation purposes and should be left unchanged.